Change the culture - Avis employé Administrative Assistant Merck

2,0
31 oct. 2008
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Salary, salary, salary, flexibility, dedicated people, work/life balance. Their salaries are better than those in the other pharma sectors for administrative personnel. They encourage flex time - I am able to telecommute at the drop of a hat - but I am in IT and have the capability. The work/life balance is fantastic. I have had colleagues who got great time off for childbirth with complications, a colleague whos separation was put off because of the death of a very close member of the family. And most people are very, very dedicated - putting in more hours than required.

Inconvénients

Awful Culture - I have worked at other big pharma in the NJ area and they are the worst. J&J ranks among the best of the best. The looked down upon status of administrative personnel - many of our admin's have college and advanced degrees and are still treated like second class citizens in the Merck world. There is no "management" track for the title and therefore we are considered lower than low. The constant atmosphere of "I am next to be laid off" - makes for terrible employee morale. Extreme offshoring - but then I work in IT. Non-recgonition and feedback.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout